High serum progesterone associated with infertility in a woman with nonclassic congenital adrenal hyperplasia

Nonclassic congenital adrenal hyperplasia (NCAH) is an autosomal‐recessive disorder caused by 21‐hydroxylase deficiency and manifests as hirsutism and oligomenorrhea due to excess adrenal androgen and progesterone. We report a case of a woman with NCAH who showed continuous high serum progesterone levels in the follicular phase associated with impaired folliculogenesis. NCAH was diagnosed based on high 17‐hydroxyprogesterone levels after rapid adrenocorticotropic hormone loading, and three heterozygous missense mutations in CYP21A2, encoding 21‐hydroxylase, were identified. Recurrent failure of in vitro fertilization programs occurred because of empty follicles and preterm rupture of leading follicles, and vaginal stenosis with a hypoplastic cervix. Glucocorticoid administration normalized serum progesterone levels, restored folliculogenesis, and stretched the vaginal wall, which contributed to the success of the in vitro fertilization program. The patient delivered at term following blastocyst transfer. Correction of hyperandrogenism and high progesterone levels using glucocorticoids may improve fertility in women with NCAH.

[1]  M. Shozu,et al.  Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer. , 2016, Fertility and sterility.

[2]  M. Yau,et al.  21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia , 2016 .

[3]  H. Falhammar,et al.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome , 2015, Endocrine.

[4]  R. Auchus,et al.  Adrenal steroidogenesis and congenital adrenal hyperplasia. , 2015, Endocrinology and metabolism clinics of North America.

[5]  Diagnostic evaluation of the infertile female: a committee opinion. , 2015, Fertility and sterility.

[6]  D. Pignatelli Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome. , 2013, Frontiers of hormone research.

[7]  I. Silva,et al.  Neonatal screening for congenital adrenal hyperplasia. , 2012, Revista da Associacao Medica Brasileira.

[8]  J. Golmard,et al.  Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  J. L. San Millán,et al.  A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. , 2008, The Journal of clinical endocrinology and metabolism.

[10]  C. Bouvattier,et al.  Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  C. Sweep,et al.  Fertility in Patients with Congenital Adrenal Hyperplasia , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[12]  P. Claman Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[13]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[14]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[15]  V. Rohmer,et al.  21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. , 2000, American journal of obstetrics and gynecology.

[16]  A. Braun,et al.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. , 2000, The Journal of clinical endocrinology and metabolism.